Immunosuppressive effect of tacrolimus (FK-506). Bone xenografts in rabbits

Acta Orthopaedica Scandinavica

Volumn 67, Issue 4, 1996, Pages 389-392

  Ikebe, Shuji ^a   Masumi, Shogo ^a   Yano, Hirokazu ^a   Fukunaga, Tsutana ^a   Shimizu, Kei ^a   Shin, Shuta ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE GRAFT; BONE MARROW; CONTROLLED STUDY; DOG; ILIAC BONE; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; MALE; NONHUMAN; OSSIFICATION; RABBIT; REVASCULARIZATION; TIME; XENOGRAFT;

EID: 0029803323     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.3109/17453679609002337     Document Type: Article

References (13)

1. Beek Y, Akiyama N. Effect of FK-506 and cyclosporin on human lymphocyte responses in vitro. Transplant Proc 1989; 21 (3): 3464-7.
2. Dennert G. Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens. J Immunol 1974; 113 (1): 201-8.
3. Escobar M R, Sigel M M. Effects of lymphoid cells and serum on target cells in xenogeneic cell-culture systems. Proc Soc Exp Biol Med 1970; 134 (3): 744-7.
4. Gelberman R H, Khabie V, Cahill C J. The revascularization of healing flexor tendons in the digital sheath. J Bone Joint Surg (Am) 1991; 73 (6): 868-81.
5. Grant C K, Avis P J, Hali J G, Alexander P. Evidence for the role of antibody in the cytotoxic action of lymph cells on xenogeneic target cells. Transplantation 1971; 11 (3): 356-8.
6. Harding B, MacLennan I C. The distribution of antibody and antibody-producing cells after immunization with xenogeneic cells. Immunology 1972; 23 (1): 35-43.
7. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiotics 1987; 40 (9): 1249-55.
8. Markus P M, van den Brink M R, Luchs B A, Fung J J, Starzl T E, Hiserodt J C. Effects of in vitro treatment with FK-506 on natural killer cells in rats. Transplantation 1991; 51 (4): 913-5.
9. Moller G, Svehag S E. Specificity of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells. Cell Immunol 1972; 4 (1): 1-19.
10. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK-506 in heterotopic cardiac allotransplantation in rats. Transplantation 1987; 44 (6): 734-8.
11. Thomson A W. FK-506: profile of an important new immunosuppressant. Transplant Rev 1990; 4 (1): 1-13.
12. Wasik M, Gorski A, Stepien-Sopniewska B, Lagodzinski Z. Effect of FK-506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. Transplantation 1991; 51 (1): 268-70.
13. Yano H, Masumi S, Fukunaga T, Ikebe S. Quantitative analysis of revascularisation and new bone formation in experimental bone grafts. Int Orthop 1993; 17 (2): 109-12.